5Y Capital

The company operates as an institutional venture capital manager. It establishes closed-end investment funds, typically structured as limited partnerships (often in Cayman and similar jurisdictions), and raises capital commitments from institutional limited partners such as sovereign wealth funds, endowments, pensions, family offices and funds-of-funds. These funds are denominated in both USD and RMB to address cross-border and onshore investment needs.

The firm then deploys this capital into equity investments in early to growth-stage technology, consumer and healthcare businesses, using specialised fund strategies (e.g., Evolution funds for early/growth stages and Growth funds for later-stage rounds). It creates value by sourcing deal flow, performing due diligence, helping portfolio companies scale, and ultimately exiting positions through IPOs, trade sales or secondary transactions. Value created in the portfolio flows back to limited partners as capital gains, with the manager earning fees and carried interest for running the funds and generating returns.

5Y Capital is a China-headquartered venture capital firm (formerly Morningside Venture Capital) managing over US$5 billion in assets from global institutional investors. It raises closed-end USD and RMB funds and invests primarily in early to growth-stage technology, consumer and healthcare companies, with a track record including major Chinese tech exits.

The firm structures multiple limited partnership vehicles and co-investment funds, such as its Evolution and Growth series, to provide equity capital and portfolio support to high-growth companies. Its revenues come from management fees and performance allocations (carried interest) paid by fund limited partners; underlying portfolio companies receive investment capital rather than paying for services directly.